Lv3
206 积分 2024-10-27 加入
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
3小时前
已完结
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large Bcell lymphoma therapy: A Meta-analysis
10天前
已关闭
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large Bcell lymphoma therapy: A Meta-analysis
11天前
已关闭
Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma
17天前
已完结
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
18天前
已完结
Mosunetuzumab Monotherapy Demonstrates Durable Efficacy with a Manageable Safety Profile in Patients with Relapsed/Refractory Follicular Lymphoma Who Received ≥2 Prior Therapies: Updated Results from a Pivotal Phase II Study
21天前
已关闭
Characteristics of second primary malignancies following bispecific antibodies therapy
29天前
已完结
Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis
1个月前
已完结
Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis
1个月前
已完结
Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma
1个月前
已完结
Preparation of AgBiS2 thin films with vapor-assisted solution method for flexible near-infrared photodetectors
10天前
已采纳
A phase III clinical trial of GC1111 as an enzyme replacement therapy in previously untreated mucopolysaccharidosis type II (Hunter syndrome) patients: A double-blind, randomized, active-controlled (part 1) and open-labeled, historical placebo-controlled (part 2) study
10天前
已采纳
皖公网安备34019202002308
